Clinical trials in Bobigny – page 2

214 clinical trials in Bobigny, France. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in FranceEssaisCliniques.fr

Bobigny at a glance

214

clinical trials

Paediatric trials0
Research sites0

Quick filters

214 trials in Bobigny

Open in trial search

Acute leukaemia

Recruiting

A study of enzomenib in adult patients with relapsed or refractory acute leukemia, including those with MLL rearrangement or NPM1 mutation.

InvestigationalNo placebo

A study of enzomenib in adult patients with relapsed or refractory acute leukemia, including those with MLL rearrangement or NPM1 mutation.

InvestigationalNo placebo

France

Participants:0–17 years · 18–64 years · 65+ years
Sponsor:Sumitomo Pharma America Inc.

Contact Research Centre

Arthritis infective

Recruiting

A study testing prednisone combined with antibiotics compared to antibiotics alone in adults with septic arthritis to improve joint health

Registered drug

A study testing prednisone combined with antibiotics compared to antibiotics alone in adults with septic arthritis to improve joint health

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Prednisone
Sponsor:Assistance Publique Hopitaux De Paris

Contact Research Centre

Squamous cell carcinoma of head and neck

Recruiting

Study of ivonescimab alone or with ligufalimab versus pembrolizumab for patients with recurrent or metastatic head and neck squamous cell cancer

Registered drugNo placebo

Study of ivonescimab alone or with ligufalimab versus pembrolizumab for patients with recurrent or metastatic head and neck squamous cell cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Ivonescimab
Sponsor:Groupe Oncologie Radiotherapie Tete Cou

Contact Research Centre

Acute myeloid leukaemia

Recruiting

A Study Comparing Two Treatment Schedules of Venetoclax and Azacitidine in Adults with Newly Diagnosed Acute Myeloid Leukemia Not Suitable for Intensive Treatment

Registered drugNo placebo

A Study Comparing Two Treatment Schedules of Venetoclax and Azacitidine in Adults with Newly Diagnosed Acute Myeloid Leukemia Not Suitable for Intensive Treatment

Registered drugNo placebo

France

Participants:65+ years
Substances:Azacitidine
Sponsor:Institut Gustave Roussy

Contact Research Centre

Breast cancer+2

Recruiting

A Study Comparing RLY-2608 and Fulvestrant with Capivasertib and Fulvestrant for Patients with PIK3CA-Mutant Hormone Receptor Positive, HER2-Negative Advanced Breast Cancer

Registered drugNo placebo

A Study Comparing RLY-2608 and Fulvestrant with Capivasertib and Fulvestrant for Patients with PIK3CA-Mutant Hormone Receptor Positive, HER2-Negative Advanced Breast Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Capivasertib
Sponsor:Relay Therapeutics Inc.

Contact Research Centre

Cutaneous lupus erythematosus

Recruiting

Comparing lenalidomide and methotrexate for patients with difficult-to-treat cutaneous lupus erythematosus

Registered drugNo placebo

Comparing lenalidomide and methotrexate for patients with difficult-to-treat cutaneous lupus erythematosus

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Lenalidomide
Sponsor:Assistance Publique Hopitaux De Paris

Contact Research Centre

Hepatitis alcoholic

Recruiting

Study of N-acetylcysteine and prednisolone combination versus extended prednisolone treatment in patients with severe alcoholic hepatitis

Registered drug

Study of N-acetylcysteine and prednisolone combination versus extended prednisolone treatment in patients with severe alcoholic hepatitis

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Acetylcysteine
Sponsor:Centre Hospitalier Universitaire De Lille

Contact Research Centre

Acute lymphocytic leukaemia+1

Recruiting

Study of olverembatinib with chemotherapy versus standard therapy in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

Registered drugNo placebo

Study of olverembatinib with chemotherapy versus standard therapy in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Cytarabine
Sponsor:Ascentage Pharma Group Inc.

Contact Research Centre

Primary biliary cholangitis

Recruiting

Study of Seladelpar Treatment in Patients with Primary Biliary Cholangitis and Compensated Cirrhosis

Investigational

Study of Seladelpar Treatment in Patients with Primary Biliary Cholangitis and Compensated Cirrhosis

Investigational

France

Participants:18–64 years · 65+ years
Substances:Seladelpar
Sponsor:Gilead Sciences Inc.

Contact Research Centre

Study on the Safety and Immune Response of the MVA-BN Vaccine Booster for Monkeypox Prevention in Previously Vaccinated Patients

Recruiting

Registered drugNo placebo

Study on the Safety and Immune Response of the MVA-BN Vaccine Booster for Monkeypox Prevention in Previously Vaccinated Patients

Registered drugNo placebo

France

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Modified Vaccinia Ankara – Bavarian Nordic Live Virus
Sponsor:The Public Health Agency Of Sweden

Contact Research Centre

Plasma cell myeloma

Recruiting

Study of elranatamab and lenalidomide combination versus standard chemotherapy and transplant in newly diagnosed multiple myeloma patients

Registered drugNo placebo

Study of elranatamab and lenalidomide combination versus standard chemotherapy and transplant in newly diagnosed multiple myeloma patients

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Bortezomib
Sponsor:Intergroupe Francophone Du Myelome

Contact Research Centre

Asthma

Recruiting

Study on Stopping Dupilumab in Patients with Severe Asthma Who Have Been on the Drug for Over 3 Years

Registered drugNo placebo

Study on Stopping Dupilumab in Patients with Severe Asthma Who Have Been on the Drug for Over 3 Years

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Dupilumab
Sponsor:Centre Hospitalier Universitaire De Toulouse

Contact Research Centre

Other cities in France

The busiest research cities in the country

All 382 cities in France

Clinical research in Bobigny

What the registry says about research in the country

01 Oncology & Hematology

Groundbreaking research focusing on multiple myeloma treatments and innovative therapies for chronic myeloid leukemia. Studies evaluating new treatment approaches for pancreatic adenocarcinoma and advanced lung cancer.

Multiple Myeloma Treatment Innovations
Leukemia Therapy Advancement
Pancreatic Cancer Treatment

Clinical trials examining both fixed-duration and continuous therapy protocols for better patient outcomes.

02 Respiratory Medicine

Investigation of novel treatments for pulmonary fibrosis and management strategies for severe asthma. Studies focusing on improving lung function and quality of life for patients with progressive respiratory conditions.

Idiopathic Pulmonary Fibrosis
Severe Asthma Management
Progressive Pulmonary Conditions

Evaluating both new therapeutic agents and treatment withdrawal strategies in controlled patients.

03 Infectious Diseases

Research on preventive measures against HIV infection and innovative approaches to monkeypox prevention. Studies evaluating long-acting medications and vaccine effectiveness.

HIV Prevention Strategies
Monkeypox Vaccination
Immunization Research

Focus on developing better prophylactic treatments and improving vaccine delivery methods.

04 Cardiovascular Health

Studies addressing acute myocardial infarction pain management and prevention of heart failure. Innovative approaches to cardiac care and treatment optimization.

Heart Failure Prevention
Acute Cardiac Care
Pain Management Innovation

Evaluating new combinations of medications for improved cardiovascular outcomes.

Back to France All countries